Insider · CIK 0001737329

Iannone Robert

Reports to the SEC for 6 companies · DUBLIN 4

sec.gov

Transactions

Companies

Filings

CIK

0001737329

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-27	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)M Exercise/Conversion	EVP, Global Head of R&D & CMO	MExercise/Conversion	−884 sh	—	—	0
2026-08-27	JAZZJazz Pharmaceuticals plcS Sale	EVP, Global Head of R&D & CMO	SSale	−300 sh	$252.76	−$75.8K	65,686
2026-08-27	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Global Head of R&D & CMO	MExercise/Conversion	+26.1K sh	$113.10	+$2.95M	111,223
2026-08-27	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Global Head of R&D & CMO	MExercise/Conversion	+884 sh	$113.10	+$100K	112,107
2026-08-27	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Global Head of R&D & CMO	MExercise/Conversion	+27.6K sh	$137.12	+$3.78M	139,691
2026-08-27	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Global Head of R&D & CMO	MExercise/Conversion	+2,916 sh	$137.12	+$400K	142,607
2026-08-27	JAZZJazz Pharmaceuticals plcS Sale	EVP, Global Head of R&D & CMO	SSale	−18.2K sh	$247.86	−$4.51M	124,420
2026-08-27	JAZZJazz Pharmaceuticals plcS Sale	EVP, Global Head of R&D & CMO	SSale	−11.4K sh	$248.67	−$2.84M	112,997
2026-08-27	JAZZJazz Pharmaceuticals plcS Sale	EVP, Global Head of R&D & CMO	SSale	−18.1K sh	$250.02	−$4.53M	94,884
2026-08-27	JAZZJazz Pharmaceuticals plcS Sale	EVP, Global Head of R&D & CMO	SSale	−19.6K sh	$250.60	−$4.92M	75,245
2026-08-27	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Global Head of R&D & CMO	MExercise/Conversion	−27.6K sh	—	—	0
2026-08-27	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Global Head of R&D & CMO	MExercise/Conversion	−26.1K sh	—	—	0
2026-08-27	JAZZJazz Pharmaceuticals plcS Sale	EVP, Global Head of R&D & CMO	SSale	−9,259 sh	$251.95	−$2.33M	65,986
2026-08-27	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)M Exercise/Conversion	EVP, Global Head of R&D & CMO	MExercise/Conversion	−2,916 sh	—	—	0
2026-07-09	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+60K sh	—	—	60,000
2026-06-30	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Global Head of R&D & CMO	FTax Payment	−3,764 sh	$237.72	−$895K	85,107
2026-06-29	AUTLAutolus Therapeutics plc · Share Option (Right to Buy)A Award	Director	AAward	+47.5K sh	—	—	47,500
2026-06-29	AUTLAutolus Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+31.7K sh	—	—	31,667
2026-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Global Head of R&D & CMO	FTax Payment	−6,209 sh	$188.69	−$1.17M	88,871
2026-02-26	JAZZJazz Pharmaceuticals plcA Award	EVP, Global Head of R&D & CMO	AAward	+14.8K sh	—	—	95,080
2026-01-16	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Global Head of R&D & CMO	FTax Payment	−4,140 sh	$171.16	−$709K	80,258
2026-01-16	JAZZJazz Pharmaceuticals plcA Award	EVP, Global Head of R&D & CMO	AAward	+11.7K sh	—	—	84,398
2025-11-17	JAZZJazz Pharmaceuticals plcS Sale	EVP, Global Head of R&D & CMO	SSale	−7,159 sh	$168.26	−$1.2M	72,628
2025-03-10	JAZZJazz Pharmaceuticals plcS Sale	EVP, Global Head of R&D & CMO	SSale	−2,403 sh	$138.41	−$333K	79,621
2025-03-07	JAZZJazz Pharmaceuticals plcS Sale	EVP, Global Head of R&D & CMO	SSale	−1,548 sh	$140.00	−$217K	82,024
2025-03-07	JAZZJazz Pharmaceuticals plcS Sale	EVP, Global Head of R&D & CMO	SSale	−5,532 sh	$138.21	−$765K	83,572
2025-03-05	JAZZJazz Pharmaceuticals plcD Disposition to Issuer	EVP, Global Head of R&D & CMO	DDisposition to Issuer	−5,239 sh	$138.95	−$728K	89,104
2025-02-27	JAZZJazz Pharmaceuticals plcA Award	EVP, Global Head of R&D & CMO	AAward	+17.7K sh	—	—	85,484
2025-02-27	JAZZJazz Pharmaceuticals plcA Award	EVP, Global Head of R&D & CMO	AAward	+8,859 sh	—	—	94,343
2025-01-17	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Global Head of R&D & CMO	FTax Payment	−2,181 sh	$122.62	−$267K	67,766
2025-01-17	JAZZJazz Pharmaceuticals plcA Award	EVP, Global Head of R&D & CMO	AAward	+7,506 sh	—	—	69,947
2024-06-11	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+24.2K sh	—	—	24,200
2024-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Global Head of R&D & CMO	FTax Payment	−4,294 sh	$117.53	−$505K	62,226
2024-03-01	JAZZJazz Pharmaceuticals plcA Award	EVP, Global Head of R&D & CMO	AAward	+16.9K sh	—	—	66,520
2024-01-17	JAZZJazz Pharmaceuticals plcA Award	EVP, Global Head of R&D & CMO	AAward	+5,970 sh	—	—	51,322
2024-01-17	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Global Head of R&D & CMO	FTax Payment	−1,730 sh	$119.13	−$206K	49,592
2023-06-13	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+22.4K sh	—	—	22,383
2023-06-05	JAZZJazz Pharmaceuticals plcD Disposition to Issuer	EVP, Global Head of R&D & CMO	DDisposition to Issuer	−1,311 sh	$129.73	−$170K	45,315
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.7K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,850 sh	—	—	0
2023-05-03	Jounce Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.4K sh	—	—	0
2023-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Global Head of R&D & CMO	FTax Payment	−2,274 sh	$142.78	−$325K	46,489
2023-03-03	JAZZJazz Pharmaceuticals plcA Award	EVP, Global Head of R&D & CMO	AAward	+12.4K sh	—	—	48,763
2022-12-09	JAZZJazz Pharmaceuticals plcS Sale	EVP, Global Head of R&D & CMO	SSale	−1,844 sh	$151.54	−$279K	36,316
2022-06-24	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-06-09	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,538
2022-06-06	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Global Head of R&D & CMO	FTax Payment	−1,295 sh	$149.25	−$193K	38,109
2022-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Global Head of R&D & CMO	FTax Payment	−1,327 sh	$153.96	−$204K	39,257
2022-03-03	JAZZJazz Pharmaceuticals plcA Award	EVP, Global Head of R&D & CMO	AAward	+11.4K sh	—	—	40,584

Recent filings

Accepted (ET)
Aug 314
Iannone Robert0001737329-26-000016
SEC(opens sec.gov)
Jul 134
Iannone Robert0001737329-26-000013
SEC(opens sec.gov)
Jul 24
Iannone Robert0001737329-26-000010
SEC(opens sec.gov)
Jul 14
Iannone Robert0001730463-26-000099
SEC(opens sec.gov)
Mar 94
Iannone Robert0001737329-26-000006
SEC(opens sec.gov)
Mar 24
Iannone Robert0001737329-26-000004
SEC(opens sec.gov)

Companies

Address

5TH FL, WATERLOO EXCHANGE WATERLOO RD

DUBLIN 4